FDA let risky drugs into US The FDA let risky drugs from banned foreign plants into the United States Salon · Jun 18, 2025
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19 The Independent UK · Sep 5, 2024
Many pharma companies that bought electoral bonds faced regulatory actions Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco. The Hindu · Mar 19, 2024